杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/08/16 | 1,842 | 1,845 | 1,811 | 1,823 | -19 | -1% | 84,500 |
| 2012/08/15 | 1,859 | 1,859 | 1,828 | 1,842 | -17 | -0.9% | 85,500 |
| 2012/08/14 | 1,799 | 1,864 | 1,790 | 1,859 | +80 | +4.5% | 247,000 |
| 2012/08/13 | 1,758 | 1,785 | 1,757 | 1,779 | +12 | +0.7% | 92,000 |
| 2012/08/10 | 1,764 | 1,782 | 1,760 | 1,767 | -18 | -1% | 126,900 |
| 2012/08/09 | 1,760 | 1,785 | 1,737 | 1,785 | +11 | +0.6% | 227,700 |
| 2012/08/08 | 1,801 | 1,824 | 1,764 | 1,774 | -27 | -1.5% | 237,200 |
| 2012/08/07 | 1,825 | 1,825 | 1,798 | 1,801 | -45 | -2.4% | 292,800 |
| 2012/08/06 | 1,822 | 1,866 | 1,816 | 1,846 | +30 | +1.7% | 285,100 |
| 2012/08/03 | 1,771 | 1,836 | 1,739 | 1,816 | +68 | +3.9% | 392,600 |
| 2012/08/02 | 1,735 | 1,765 | 1,727 | 1,748 | +27 | +1.6% | 170,100 |
| 2012/08/01 | 1,709 | 1,730 | 1,702 | 1,721 | +12 | +0.7% | 115,400 |
| 2012/07/31 | 1,729 | 1,733 | 1,701 | 1,709 | -26 | -1.5% | 112,100 |
| 2012/07/30 | 1,700 | 1,735 | 1,686 | 1,735 | +31 | +1.8% | 132,800 |
| 2012/07/27 | 1,742 | 1,742 | 1,698 | 1,704 | -38 | -2.2% | 173,500 |
| 2012/07/26 | 1,737 | 1,744 | 1,715 | 1,742 | -2 | -0.1% | 132,700 |
| 2012/07/25 | 1,750 | 1,768 | 1,723 | 1,744 | +27 | +1.6% | 201,800 |
| 2012/07/24 | 1,693 | 1,732 | 1,693 | 1,717 | +34 | +2% | 206,400 |
| 2012/07/23 | 1,685 | 1,722 | 1,681 | 1,683 | -8 | -0.5% | 105,900 |
| 2012/07/20 | 1,721 | 1,750 | 1,690 | 1,691 | -64 | -3.6% | 226,100 |
| 2012/07/19 | 1,741 | 1,760 | 1,735 | 1,755 | +15 | +0.9% | 195,800 |
| 2012/07/18 | 1,737 | 1,761 | 1,735 | 1,740 | -6 | -0.3% | 132,500 |
| 2012/07/17 | 1,732 | 1,761 | 1,717 | 1,746 | +17 | +1% | 117,300 |
| 2012/07/13 | 1,728 | 1,751 | 1,713 | 1,729 | -4 | -0.2% | 97,700 |
| 2012/07/12 | 1,730 | 1,753 | 1,721 | 1,733 | +7 | +0.4% | 117,900 |
| 2012/07/11 | 1,745 | 1,745 | 1,715 | 1,726 | -21 | -1.2% | 86,500 |
| 2012/07/10 | 1,736 | 1,773 | 1,716 | 1,747 | +29 | +1.7% | 307,200 |
| 2012/07/09 | 1,730 | 1,730 | 1,704 | 1,718 | +12 | +0.7% | 190,800 |
| 2012/07/06 | 1,704 | 1,733 | 1,688 | 1,706 | -26 | -1.5% | 163,000 |
| 2012/07/05 | 1,750 | 1,757 | 1,712 | 1,732 | -7 | -0.4% | 150,200 |
| 2012/07/04 | 1,755 | 1,755 | 1,724 | 1,739 | +27 | +1.6% | 166,900 |
| 2012/07/03 | 1,675 | 1,714 | 1,672 | 1,712 | +56 | +3.4% | 186,100 |
| 2012/07/02 | 1,676 | 1,687 | 1,648 | 1,656 | -22 | -1.3% | 122,700 |
| 2012/06/29 | 1,632 | 1,692 | 1,632 | 1,678 | +46 | +2.8% | 90,000 |
| 2012/06/28 | 1,631 | 1,656 | 1,626 | 1,632 | -10 | -0.6% | 158,000 |
| 2012/06/27 | 1,633 | 1,642 | 1,625 | 1,642 | +10 | +0.6% | 35,000 |
| 2012/06/26 | 1,636 | 1,653 | 1,628 | 1,632 | -4 | -0.2% | 68,000 |
| 2012/06/25 | 1,654 | 1,655 | 1,626 | 1,636 | +16 | +1% | 175,000 |
| 2012/06/22 | 1,615 | 1,636 | 1,613 | 1,620 | +14 | +0.9% | 93,000 |
| 2012/06/21 | 1,610 | 1,617 | 1,592 | 1,606 | -4 | -0.2% | 174,000 |
| 2012/06/20 | 1,594 | 1,626 | 1,594 | 1,610 | +15 | +0.9% | 170,000 |
| 2012/06/19 | 1,572 | 1,606 | 1,572 | 1,595 | +12 | +0.8% | 125,000 |
| 2012/06/18 | 1,590 | 1,600 | 1,581 | 1,583 | -7 | -0.4% | 107,000 |
| 2012/06/15 | 1,586 | 1,605 | 1,586 | 1,590 | +6 | +0.4% | 158,000 |
| 2012/06/14 | 1,600 | 1,600 | 1,576 | 1,584 | -11 | -0.7% | 83,000 |
| 2012/06/13 | 1,590 | 1,607 | 1,588 | 1,595 | -6 | -0.4% | 57,000 |
| 2012/06/12 | 1,599 | 1,605 | 1,585 | 1,601 | +1 | +0.1% | 65,000 |
| 2012/06/11 | 1,638 | 1,638 | 1,589 | 1,600 | -20 | -1.2% | 130,000 |
| 2012/06/08 | 1,643 | 1,643 | 1,597 | 1,620 | -13 | -0.8% | 156,000 |
| 2012/06/07 | 1,612 | 1,647 | 1,612 | 1,633 | +9 | +0.6% | 107,000 |
3001～
3050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
